IRadimed Corporation reported strong first-quarter results, with revenue exceeding internal expectations and a significant increase in income before taxes. The company's IV pump revenue grew by nearly 32% year-over-year, and backlog increased from already elevated levels.
First quarter bookings and revenue surpassed internal expectations.
IV pump revenue increased by nearly 32% compared to the previous year.
Income before taxes increased by 112%, demonstrating the quarter's strength.
Backlog grew from already high levels at the end of the previous year.
Due to the significant uncertainty surrounding the impact of COVID-19, the Company believes it is prudent to refrain from providing financial guidance at this time. The Company continues to monitor the circumstances around the pandemic and will provide financial guidance once there is more certainty around the pandemic’s impact on its business.
Analyze how earnings announcements historically affect stock price performance